share_log

AgeX Therapeutics | PRER14A: Preliminary revised proxy soliciting materials

SEC announcement ·  Oct 5, 2022 16:06
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more